Clinical Management of Acute HIV Infection: Best Practice Remains Unknown

被引:42
作者
Bell, Sigall K. [2 ]
Little, Susan J. [3 ]
Rosenberg, Eric S. [1 ]
机构
[1] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Div Infect Dis, Boston, MA 02114 USA
[2] Beth Israel Deaconess Med Ctr, Div Infect Dis, Boston, MA 02215 USA
[3] Univ Calif San Diego, Div Infect Dis, San Diego, CA 92103 USA
基金
美国国家卫生研究院;
关键词
HUMAN-IMMUNODEFICIENCY-VIRUS; COMBINATION ANTIRETROVIRAL THERAPY; TRANSMITTED DRUG-RESISTANCE; T-CELL RESPONSES; VIRAL LOAD; TYPE-1; INFECTION; RESTORATION; ZIDOVUDINE; IMPACT; REPLICATION;
D O I
10.1086/655655
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Best practice for the clinical management of acute human immunodeficiency virus (HIV) infection remains unknown. Although some data suggest possible immunologic, virologic, or clinical benefit of early treatment, other studies show no difference in these outcomes over time, after early treatment is discontinued. The literature on acute HIV infection is predominantly small nonrandomized studies, which further limits interpretation. As a result, the physician is left to grapple with these uncertainties while making clinical decisions for patients with acute HIV infection. Here we review the literature, focusing on the potential advantages and disadvantages of treating acute HIV infection outlined in treatment guidelines, and summarize the presentations on clinical management of acute HIV infection from the 2009 Acute HIV Infection Meeting in Boston, Massachusetts.
引用
收藏
页码:S278 / S288
页数:11
相关论文
共 73 条
[1]   Primary care guidelines for the management of persons infected with human immunodeficiency virus: Recommendations of the HIV Medicine Association of the Infectious Diseases Society of America [J].
Aberg, JA ;
Gallant, JE ;
Anderson, J ;
Oleske, JM ;
Libman, H ;
Currier, JS ;
Stone, VE ;
Kaplan, JE .
CLINICAL INFECTIOUS DISEASES, 2004, 39 (05) :609-629
[2]   Maximum suppression of HIV replication leads to the restoration of HIV-specific responses in early HIV disease [J].
Al-Harthi, L ;
Siegel, J ;
Spritzler, J ;
Pottage, J ;
Agnoli, M ;
Landay, A .
AIDS, 2000, 14 (07) :761-770
[3]   Tolerability and Efficacy of PI Versus NNRTI-Based Regimens in Subjects Receiving HAART During Acute or Early HIV Infection [J].
Apuzzo, Linda G. ;
Vaida, Florin ;
Gallant, Joel E. ;
Ernstron, Karin B. ;
Little, Susan J. ;
Routy, Jean-Pierre ;
Collier, Ann C. ;
Conway, Brian ;
Markowitz, Martin H. ;
Hecht, Frederick M. ;
Walker, Bruce D. ;
Connick, Elizabeth ;
Margolick, Joseph B. .
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2009, 50 (03) :267-275
[4]   Transmitted drug resistant HIV-1 and association with virologic and CD4 cell count response to combination Antiretroviral therapy in the EuroSIDA study [J].
Bannister, Wendy P. ;
Cozzi-Lepri, Alessandro ;
Clotet, Bonaventura ;
Mocroft, Amanda ;
Kjaer, Jesper ;
Reiss, Peter ;
von Wyl, Viktor ;
Lazzarin, Adriano ;
Katlama, Christine ;
Phillips, Andrew N. ;
Ruiz, Lidia ;
Lundgren, Jens D. .
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2008, 48 (03) :324-333
[5]  
Bell Sigall K, 2009, N Engl J Med, V360, P1540, DOI 10.1056/NEJMcpc0810840
[6]   Drug Resistance Mutations for Surveillance of Transmitted HIV-1 Drug-Resistance: 2009 Update [J].
Bennett, Diane E. ;
Camacho, Ricardo J. ;
Otelea, Dan ;
Kuritzkes, Daniel R. ;
Fleury, Herve ;
Kiuchi, Mark ;
Heneine, Walid ;
Kantor, Rami ;
Jordan, Michael R. ;
Schapiro, Jonathan M. ;
Vandamme, Anne-Mieke ;
Sandstrom, Paul ;
Boucher, Charles A. B. ;
van de Vijver, David ;
Rhee, Soo-Yon ;
Liu, Tommy F. ;
Pillay, Deenan ;
Shafer, Robert W. .
PLOS ONE, 2009, 4 (03)
[7]   High rates of forward transmission events after acute/early HIV-1 infection [J].
Brenner, Bluma G. ;
Roger, Michel ;
Routy, Jean-Pierre ;
Moisi, Daniela ;
Ntemgwa, Michel ;
Matte, Claudine ;
Baril, Jean-Guy ;
Thomas, Rejean ;
Rouleau, Danielle ;
Bruneau, Julie ;
Leblanc, Roger ;
Legault, Mario ;
Tremblay, Cecile ;
Charest, Hugues ;
Wainberg, Mark A. .
JOURNAL OF INFECTIOUS DISEASES, 2007, 195 (07) :951-959
[8]   Virologic, immunologic, and clinical benefits from early combined antiretroviral therapy in infants with perinatal HIV-1 infection. [J].
Chiappini, E ;
Galli, L ;
Tovo, PA ;
Gabiano, C ;
Gattinara, GC ;
Guarino, A ;
Baddato, R ;
Giaquinto, C ;
Lisi, C ;
de Martino, M .
AIDS, 2006, 20 (02) :207-215
[9]  
Clements Mark, 2003, HIV Med, V4, P332
[10]  
*DEP HLTH HUM SERV, 2009, GUID AD AD WORK GROU